PURIFY-TIMI 81 is a multinational, multicenter, randomized, parallel, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of intravenously administered YN001 compared with placebo in participants with coronary atherosclerosis who are receiving background therapy for CV risk factors management. PURIFY-TIMI 81 on ClinicalTrials.gov CONTACT US about PURIFY